CUI JINGRONG JEAN (Chief Scientific Officer) sold 8.0% of their position (55.50K shares) of TURNING POINT THERAPEUTICS, INC. on the open market

Open‑market sale worth $2.96M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 8 sales

CUI JINGRONG JEAN

Filed: 5/7/2020ACC: 0001209191-20-027784

InsiderCUI JINGRONG JEANCIK 1772259

→

IssuerTURNING POINT THERAPEUTICS, INC.CIK 1595893

DirectorOfficer10% Owner· Chief Scientific Officer

Since Apr 2019

-55.50K

Net shares

Net seller

$2.96M

Total sold

Open market trades

0B · 8S

Total transactions

55.50K disposed

Non-Derivative Transactions8

Common Stock

Indirect

S · Sale

−4K

Price / share

$53.05

Trade value

$212.09K

% of position

0.6%

5/5/2020

693.38K→689.38K

Common Stock

Indirect

S · Sale

−8.72K

Price / share

$54.04

Trade value

$471.12K

% of position

1.3%

5/5/2020

689.38K→680.67K

Common Stock

Indirect

S · Sale

−5.78K

Price / share

$54.67

Trade value

$316.21K

% of position

0.8%

5/5/2020

680.67K→674.88K

Common Stock

Indirect

S · Sale

−6.07K

Price / share

$52.54

Trade value

$319.02K

% of position

0.9%

5/6/2020

674.88K→668.81K

Common Stock

Indirect

S · Sale

−12.43K

Price / share

$53.13

Trade value

$660.30K

% of position

1.9%

5/6/2020

668.81K→656.38K

Common Stock

Indirect

S · Sale

−5.31K

Price / share

$52.22

Trade value

$277.08K

% of position

0.8%

5/7/2020

656.38K→651.08K

Common Stock

Indirect

S · Sale

−11.86K

Price / share

$53.05

Trade value

$629.39K

% of position

1.8%

5/7/2020

651.08K→639.21K

Common Stock

Indirect

S · Sale

−1.33K

Price / share

$53.70

Trade value

$71.42K

% of position

0.2%

5/7/2020

639.21K→637.88K

Total

Net shares

−55.50K

Net value

-$2.96M

Security	Date	Type	Shares	Price / Share	Trade Value	% of Position	Held Before	Held After
Common Stock Indirect	5/5/2020	S · Sale	−4K	$53.05	$212.09K	0.6%	693.38K	689.38K
Common Stock Indirect	5/5/2020	S · Sale	−8.72K	$54.04	$471.12K	1.3%	689.38K	680.67K
Common Stock Indirect	5/5/2020	S · Sale	−5.78K	$54.67	$316.21K	0.8%	680.67K	674.88K
Common Stock Indirect	5/6/2020	S · Sale	−6.07K	$52.54	$319.02K	0.9%	674.88K	668.81K
Common Stock Indirect	5/6/2020	S · Sale	−12.43K	$53.13	$660.30K	1.9%	668.81K	656.38K
Common Stock Indirect	5/7/2020	S · Sale	−5.31K	$52.22	$277.08K	0.8%	656.38K	651.08K
Common Stock Indirect	5/7/2020	S · Sale	−11.86K	$53.05	$629.39K	1.8%	651.08K	639.21K
Common Stock Indirect	5/7/2020	S · Sale	−1.33K	$53.70	$71.42K	0.2%	639.21K	637.88K
Total			−55.50K		-$2.96M

Derivative Transactions0

No derivative transactions reported

Non-Derivative Holdings (Post-Transaction)2

Common Stock

Indirect

Shares owned300K

Common Stock

Direct

Shares owned1M

Total

1M direct·300K indirect1.30M

Security Title	Shares Owned	Ownership Type
Common Stock	300K	Indirect
Common Stock	1M	Direct
Total	1.30M	1M direct·300K indirect

Derivative Holdings (Post-Transaction)0

No derivative holdings reported